We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Breath Test Detects Vitamin B12 Levels

By LabMedica International staff writers
Posted on 29 Jun 2011
Diagnosis of vitamin B12 deficiency can be made using a simple, noninvasive, low-cost breath test.

Scientists have developed a test to detect the levels of vitamin B12 using a person's breath, allowing for a cheaper, faster diagnosis that could help to avoid the potentially fatal symptoms of B12 deficiency. More...


Vitamin B12 plays a crucial role in the breakdown of a common preservative called sodium propionate in bakery products, into carbon dioxide. Therefore, investigators decided to administer propionate to subjects, which would be broken down with the aid of vitamin B12 in the body, and then measure the resultant carbon dioxide.

The initial testing of the B12 breath test conducted measurements on subjects with chronic pancreatitis, Crohn's disease, and small intestinal bacterial overgrowth, as well as patients over 65, all of which are associated with a higher incidence of vitamin B12 deficiency.

After fasting and not smoking for 8 hours, the study participants were orally administered 50 mg of propionate and then tested every 10 minutes for the first hour and every 15 minutes for the second hour, with the best diagnostic accuracy appearing to be the 10- and 20-minute intervals.

To ascertain the accuracy of the breath test, the obtained vitamin B12 levels were compared with several blood compounds that are currently used to ascertain vitamin B12 deficiency. The results indicated that the vitamin B12 breath test is a noninvasive, sensitive, specific, and reproducible diagnostic test to detect vitamin B12 deficiency.

Lead author Dr. David Wagner said, "Initially, larger studies must be conducted including treatment of B12 deficient subjects showing resolution of the abnormal breath test results. If these results are positive, FDA approval with many study centers will need to be conducted."

The test was developed by scientists from the University of Florida at Gainesville (FL, USA) and Metabolic Solutions, Inc. (Nashua, NH, USA).

The study was published on June 23, 2011, in IOP Publishing's Journal of Breath Research.

Related Links:
University of Florida, Gainesville
Metabolic Solutions, Inc.


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Pancreas cells (left) showing early stages of malignant cancer in brown and same cells stained blue (right) indicate they are Integrin β3 (ITGB3) positive (Photo courtesy of UC San Diego Health Sciences)

Gene Signature Could Serve as Early Warning System for Aggressive Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer, with early detection remaining a major challenge. Precancerous cells must overcome significant stress and... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.